Sexual Minority Women Report Better Sexual Functioning Than Heterosexual Women
By Lori Solomon HealthDay Reporter
FRIDAY, Dec. 20, 2024 -- Sexual minority women (SMW) report better sexual functioning in midlife than their heterosexual peers, according to a study published online Dec. 17 in Menopause.
Laura A. Muratore, from the San Francisco Veterans Affairs Health Care System, and colleagues compared whether indices of sexual function differed between SMW and heterosexual midlife women veterans. The analysis included survey results from 232 participants (25 percent SMW).
The researchers found that compared with heterosexual women, SMW were more likely to endorse recent sexual activity (odds ratio, 2.20), less likely to report pain during sex (odds ratio, 0.07), and less likely to report past-month vaginal symptoms (odds ratio, 0.33); SMW also reported less impact of vaginal symptoms on sexual function (β = −0.24). High levels of distress related to sexual dysfunction were reported by both groups.
"The results of this study highlight that menopause and aging substantively affect sexual health and functioning in women veterans and, further, that experiences may vary significantly based on sexual identity," Stephanie Faubion, M.D., medical director of The Menopause Society, said in a statement. "Additional research is needed to better understand the unique needs of midlife sexual minority women and to promote the provision of affirming health care to sexual minority women veterans."
One author disclosed ties to Astellas Pharmaceuticals.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Increasing Sit-to-Stand Transitions Lowers BP in Postmenopausal Women
FRIDAY, Aug. 8, 2025 -- Changing sedentary behaviors is feasible for postmenopausal women with overweight and obesity, and increasing sit-to-stand transitions (STSTs) is...
Stopping Menopausal Hormone Therapy May Temporarily Increase Fracture Risk
WEDNESDAY, July 30, 2025 -- Stopping menopausal hormone therapy initially leads to several years of elevated fracture risk; however, this risk then decreases, first becoming...
ENDO: Superior Weight Loss Seen With Tirzepatide and Menopausal Hormone Therapy Use
TUESDAY, July 15, 2025 -- In postmenopausal women with overweight or obesity receiving tirzepatide, use of menopausal hormone therapy (MHT) is associated with superior weight loss...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.